111 related articles for article (PubMed ID: 5426933)
1. Urinary bladder carcinogenicity of N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide in female Swiss mice.
Ertürk E; Cohen SM; Bryan GT
Cancer Res; 1970 May; 30(5):1309-11. PubMed ID: 5426933
[No Abstract] [Full Text] [Related]
2. Comparative carcinogenicity in Swiss mice of N-(4-(5-nitro-2-furyl)-2-thiazolyl)acetamide and structurally related 5-nitrofurans and 4-nitrobenzenes.
Cohen SM; Lower GM; Ertürk E; Bryan GT
Cancer Res; 1973 Jul; 33(7):1593-7. PubMed ID: 4721223
[No Abstract] [Full Text] [Related]
3. Carcinogenicity of formic acid 2-[4-(5-nitro-2-furyl)-2-thiazolyl]-hydrazide in Swiss mice.
Cohen SM; Ertürk E; Bryan GT
Cancer Res; 1970 Apr; 30(4):906-12. PubMed ID: 4324549
[No Abstract] [Full Text] [Related]
4. Effect of p-hydroxyacetanilide, sodium sulfate, and L-methionine on the leukemogenicity of N-[4-(5-nitro-2-furyl)-2-thiazolyl]acetamide.
Cohen SM; Bryan GT
Cancer Res; 1978 May; 38(5):1398-405. PubMed ID: 639067
[TBL] [Abstract][Full Text] [Related]
5. Production of leukemia and stomach neoplasms in Swiss, RF, BALB-c, and C3H female mice by feeding N-[4-(5-nitro-2-furyl)-2-thiazolyl]acetamide.
Cohen SM; Ertürk E; Bryan GT
Cancer Res; 1970 Sep; 30(9):2320-5. PubMed ID: 5475478
[No Abstract] [Full Text] [Related]
6. Comparative urinary and gallbladder carcinogenicity of N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide and N-(4-(5-nitro-2-furyl)-2-thiazolyl)acetamide in the dog.
Ertürk E; Atassi SA; Yoshida O; Cohen SM; Price JM; Bryan GT
J Natl Cancer Inst; 1970 Sep; 45(3):535-42. PubMed ID: 4331642
[No Abstract] [Full Text] [Related]
7. Effect of avitaminosis A and hypervitaminosis A on urinary bladder carcinogenicity of N-(4-(5-Nitro-2-furyl)-2-thiazolyl)formamide.
Cohen SM; Wittenberg JF; Bryan GT
Cancer Res; 1976 Jul; 36(7 PT 1):2334-9. PubMed ID: 1277139
[TBL] [Abstract][Full Text] [Related]
8. Morphological effects of mitomycin C administered intravesically to normal mice and mice with N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide-induce bladder neoplasms.
Daskal Y; Soloway MS; DeFuria MD; Crooke ST
Cancer Res; 1980 Feb; 40(2):261-7. PubMed ID: 7356509
[TBL] [Abstract][Full Text] [Related]
9. The effect of gonadectomy and hormone administration on the urinary bladder carcinogenicity of N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide in male and female Swiss mice.
Yoshida O; Ertürk E; Bryan GT; Lower GM
Invest Urol; 1973 Nov; 11(3):216-20. PubMed ID: 4749422
[No Abstract] [Full Text] [Related]
10. Malignant transformation of urinary bladder in humans and in N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide-exposed Fischer rats: ultrastructure of the major components of the permeability barrier.
Merk FB; Pauli BU; Jacobs JB; Alroy J; Friedell GH; Weinstein RS
Cancer Res; 1977 Aug; 37(8 Pt 2):2843-53. PubMed ID: 872113
[No Abstract] [Full Text] [Related]
11. Pathogenesis, histology, and transplantability of urinary bladder carcinomas induced in albino rats by oral administration of N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide.
Ertürk E; Cohen SM; Price JM; Bryan GT
Cancer Res; 1969 Dec; 29(12):2219-28. PubMed ID: 5387262
[No Abstract] [Full Text] [Related]
12. [Epithelial bladder tumor induction in rats with N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide].
Vlasov NN; Pliss GB; Balin VV
Vopr Onkol; 1980; 26(3):63-7. PubMed ID: 7368659
[TBL] [Abstract][Full Text] [Related]
13. Effect of regenerative hyperplasia on the urinary bladder: carcinogenicity of sodium saccharin and N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
Cohen SM; Murasaki G; Fukushima S; Greenfield RE
Cancer Res; 1982 Jan; 42(1):65-71. PubMed ID: 7053869
[No Abstract] [Full Text] [Related]
14. Biotransformation of the bladder carcinogen N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide in mice.
Swaminathan S; Bryan GT
Cancer Res; 1984 Jun; 44(6):2331-8. PubMed ID: 6722771
[TBL] [Abstract][Full Text] [Related]
15. The use of N-(4-(5-nitro-2-furyl)-2-thiazolyl) formamide in the study of bladder cancer.
Tiltman AJ
S Afr Med J; 1972 Mar; 46(11):293-4. PubMed ID: 5018148
[No Abstract] [Full Text] [Related]
16. Ultrastructure and reversibility of bladder carcinoma of rats produced by feeding of N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide.
Pai SH; Amaral L; Werthamer S; Zak FG
Invest Urol; 1973 Sep; 11(2):125-35. PubMed ID: 4728260
[No Abstract] [Full Text] [Related]
17. The production of carcinoma of the urinary bladder in rats by feeding N-[3-(5-nitro-2-furyl)-2-thiazolyl]formamide.
Ertürk E; Price JM; Morris JE; Cohen S; Leith RS; Von Esch AM; Crovetti AJ
Cancer Res; 1967 Nov; 27(11):1998-2002. PubMed ID: 6073497
[No Abstract] [Full Text] [Related]
18. The effect of single dose N-methyl-N-nitrosourea on bladder carcinogenesis by N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide in rats.
Grossman HB; Sonda LP; Lesser ML
Invest Urol; 1981 May; 18(8):457-9. PubMed ID: 7228579
[TBL] [Abstract][Full Text] [Related]
19. Low susceptibility of analbuminemic rats to induction of bladder cancer by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
Hosaka Y; Muramatsu M; Matsushima T; Niijima T; Nagase S
Jpn J Cancer Res; 1985 Jul; 76(7):577-82. PubMed ID: 3928553
[TBL] [Abstract][Full Text] [Related]
20. Effect of peroxidase inhibitors on an in vivo metabolite of the urinary bladder carcinogen N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide in rats.
Rice JR; Spry LA; Zenser TV; Davis BB
Cancer Res; 1988 Jan; 48(2):304-9. PubMed ID: 3121171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
